Effects of onabotulinumtoxinA treatment in chronic migraine patients with and without daily headache at baseline: results from the COMPEL Study

BACKGROUND: OnabotulinumtoxinA is effective in preventing chronic migraine (CM); however, the benefit of onabotulinumtoxinA in patients with CM with daily headache is unknown because these patients are typically excluded from clinical trials. This subanalysis of the COMPEL Study assessed the efficac...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Headache Pain
Main Authors: Young, William B., Ivan Lopez, J., Rothrock, John F., Orejudos, Amelia, Manack Adams, Aubrey, Lipton, Richard B., Blumenfeld, Andrew M.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Milan 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6734507/
https://ncbi.nlm.nih.gov/pubmed/30709333
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s10194-018-0953-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados